Facet Biotech's P2P Acquisition

Facet Biotech raised a round of funding on March 09, 2010. Investors include AbbVie.

Facet Biotech, a spin-off from PDL BioPharma, is a biotechnology company that identifies and develops new drugs.…

Articles about Facet Biotech's P2P Acquisition: